Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice
- 20 June 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 33 (9) , 1170-1182
Abstract
3,4-Methylenedioxymethamphetamine (MDMA) is still one of the most consumed drugs by adolescents. Its abuse is related with cognitive impairment, which seems due to maladaptive plasticity and neural stress. In turn, new hypotheses suggest that Alzheimer’s disease (AD) may be promoted by neural stressors. To test if there is an increase in vulnerability to AD after chronic MDMA consumption, we investigated the effects of this drug on recognition memory and its neurotoxic and neuroplastic effects in a transgenic mouse model of presymptomatic familiar AD (APP/PS1 dE9, Tg). MDMA-treated animals showed recognition memory deficits, regardless of genotype, which were accompanied by changes in plasticity markers. Tg mice showed an impaired expression of Arc compared with wild-type animals, but exposure to MDMA induced an increase in the expression of this factor of the same percentage in both genotypes. However, the expression of c-fos, BDNF and p-CREB was not significantly altered by MDMA treatment in Tg mice. Although Tg mice had higher free choline levels than wild-type mice (about 123%), MDMA did not modify these levels in any case, ruling out any specific effect of this drug on the acetylcholine pathway. MDMA treatment significantly increased the presence of cortical amyloid plaques, as well as Aβ40, Aβ42 and secreted APPβ levels in Tg mice. These plaques were accompanied by increased tau phosphorylation (S199), which does not seem to occur via the canonic pathway involving AKT, CDK5 or GSK3β. The present results support previous evidences that MDMA can contribute to the amyloid cascade.Keywords
Funding Information
- European Regional Development Founds (CIBERNED: PI2016/01 and CB06/05/0024)
- Ministerio de Economía y Competitividad (FPU grants (LDC))
- Plan Nacional sobre Drogas (#2016I004)
- Ministerio de Economía y Competitividad (SAF2016-75347-R and SAF2017-84283-R)
- Generalitat de Catalunya (2017SGR979)
This publication has 69 references indexed in Scilit:
- Rapid cell death is preceded by amyloid plaque-mediated oxidative stressProceedings of the National Academy of Sciences, 2013
- Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of TauopathyJournal of Neuroscience, 2011
- Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMANeurobiology of Disease, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbensTrends in Neurosciences, 2010
- Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer’s diseaseNeurobiology of Aging, 2009
- The interactome of the amyloid β precursor protein family members is shaped by phosphorylation of their intracellular domainsMolecular Neurodegeneration, 2009
- Regulation of Amyloid β-Protein Precursor by Phosphorylation and Protein InteractionsJournal of Biological Chemistry, 2008
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Treatment with MDMA from P11–20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older ratsPsychopharmacology, 2006